Supplier · Large organisation

Teva UK Limited

Teva UK Limited has won 19 UK public contracts worth £28.5m since 28 Sep 2020. Buyers include The NHS Commissioning Board (operating under the name of NHS England), The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority"), The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS").

Company 00302461 · Companies House record · Based in Yorkshire and the Humber

Contracts: 19
Published value: £28.5mwhere stated
Without competition: 11%2 contracts
Won by SMEs: 21%of 19 with size known

Contracts won per month, last 24 months

Biggest customers

The NHS Commissioning Board (operating under the name of NHS England) 9 · £9
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") 5 · £15.6m
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") 2 · £2.86m
Department of Health and Social Care 1 · £9.6m
Ministry of Defence 1 · £296k
Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards 1 · £108k

What they supply

Medical equipment & pharmaceuticals 19 · £28.5m

All contracts won by Teva UK Limited

Contracts won by Teva UK Limited
Date	Contract	Buyer	Value
2 Mar 2021	Supply of OTFC 800 Actiq Lozenges No competition	Ministry of Defence	£296k
10 Feb 2021	NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche: Lot 1: North of England (NOFE) Tranche A	The NHS Commissioning Board (operating under the name of NHS England)	£1
10 Feb 2021	NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche: Lot 2: North of England (NOFE) Annual Tranche	The NHS Commissioning Board (operating under the name of NHS England)	£1
1 Feb 2021	Anti-Infective Drugs 3	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards	£108k
25 Jan 2021	NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.	The NHS Commissioning Board (operating under the name of NHS England)	£1
25 Jan 2021	NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.: Lot 2: Midlands and East Cytokine Modulators and other monoclonal antibodies	The NHS Commissioning Board (operating under the name of NHS England)	£1
25 Jan 2021	NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.	The NHS Commissioning Board (operating under the name of NHS England)	£1
25 Jan 2021	NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.	The NHS Commissioning Board (operating under the name of NHS England)	£1
15 Jan 2021	NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib	The NHS Commissioning Board (operating under the name of NHS England)	£1
11 Jan 2021	Teriparatide	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	£2.74m
23 Dec 2020	Antiviral Generic Medicines: Emtricitabine/Tenofovir Disoproxil	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	£118k
21 Dec 2020	NHS National Generic Pharmaceuticals Interim 2 2020: Interim 2 2020 - Hospital only products - All regions 01/02/2021 to 31/01/2022	The NHS Commissioning Board (operating under the name of NHS England)	£1
21 Dec 2020	NHS National Generic Pharmaceuticals Interim 2 2020: Interim 2 2020 - Orals (+ non-parenterals)- All regions 01/03/2021 to 28/02/2022	The NHS Commissioning Board (operating under the name of NHS England)	£1
16 Dec 2020	Oncology Generics Medicines: Lot 28 Vincristine Without Preservatives Injection	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£73,388
16 Dec 2020	Oncology Generics Medicines: Lot 30 Octreotide Vials Long Acting (Excluding Homecare)	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£3.26m
16 Dec 2020	Oncology Generics Medicines: Lot 31 Octreotide Vials Long Acting (Including Homecare)	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£50,148
16 Dec 2020	Oncology Generics Medicines: Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£11.9m
16 Dec 2020	Oncology Generics Medicines: Lot 11 Imatinib	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£341k
28 Sep 2020	Virus Testing Supplies No competition	Department of Health and Social Care	£9.6m

Contracts are matched to this supplier by company name as published in each notice. If a company appears under slightly different names, some of its contracts may be listed separately. How matching works.